Nathalie Chavarot

7PUBLICATIONS
22CO-AUTHORS
Optical technologyNanomedicineInfectious diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 16, 2022
CMV-related anterior and intermediate uveitis in a kidney transplant recipient treated with belatacept.

Antoine Morel, Amina Chahrazed Debieb, David Mrejen

|Aug 12, 2022
De novo posttransplant membranous nephropathy following BNT162b2 mRNA COVID-19 vaccine in a kidney transplant recipient.

Nathalie Chavarot, Michael Padden, Lucile Amrouche

|Feb 12, 2022
Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximab.

Antoine Morel, Sandrine Imbeaud, Anne Scemla

|Aug 25, 2021
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept.

Nathalie Chavarot, Antoine Morel, Marianne Leruez-Ville

|Dec 07, 2020
Increased incidence and unusual presentations of CMV disease in kidney transplant recipients after conversion to belatacept.

Nathalie Chavarot, Gillian Divard, Anne Scemla

|Dec 01, 2020
Is COVID-19 infection more severe in kidney transplant recipients?

Sophie Caillard, Nathalie Chavarot, Hélène Francois

Pageof 2